M.D.C. (NYSE:MDC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, Zacks.com reports.

According to Zacks, “M.D.C. Holdings, Inc. engages in homebuilding and financial service businesses in the United States. It is engaged in the construction, sale and related financing of residential housing and the acquisition and development of land for use in the Denver, Phoenix, Maryland, Virginia, mid Atlantic region, Las Vegas, Dallas, California metropolitan areas. MDC’s homebuilding subsidiaries, which operate under the name Richmond American Homes, have built and financed the American Dream. MDC’s commitment to customer satisfaction, quality and value is reflected in each home its subsidiaries build. MDC is one of the largest homebuilders in the United States. The Company’s subsidiaries also provide mortgage financing, insurance and title services, primarily for Richmond American homebuyers, through Home American Mortgage Corporation, American Home Insurance Agency, Inc. and American Home Title and Escrow Company, respectively. “

A number of other analysts also recently commented on the company. ValuEngine downgraded Intersect ENT from a “buy” rating to a “hold” rating in a research report on Monday. JPMorgan Chase & Co. upgraded M.D.C. from an “underweight” rating to a “neutral” rating in a research report on Monday. Finally, Wedbush began coverage on Uber Technologies in a research report on Wednesday, May 1st. They set an “outperform” rating and a $65.00 target price for the company. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $33.80.

Shares of MDC stock traded down $0.12 during mid-day trading on Tuesday, reaching $36.48. The stock had a trading volume of 397,582 shares, compared to its average volume of 412,259. The company has a 50 day moving average of $32.85. The company has a current ratio of 8.58, a quick ratio of 2.19 and a debt-to-equity ratio of 0.68. M.D.C. has a one year low of $25.14 and a one year high of $36.89. The company has a market capitalization of $2.22 billion, a price-to-earnings ratio of 9.93, a PEG ratio of 1.43 and a beta of 1.15.

M.D.C. (NYSE:MDC) last announced its quarterly earnings data on Tuesday, April 30th. The construction company reported $0.64 EPS for the quarter, topping the Zacks’ consensus estimate of $0.59 by $0.05. M.D.C. had a return on equity of 14.20% and a net margin of 6.90%. The company had revenue of $647.28 million during the quarter, compared to the consensus estimate of $597.26 million. During the same quarter last year, the company earned $0.63 EPS. The company’s quarterly revenue was up 6.5% on a year-over-year basis. As a group, sell-side analysts expect that M.D.C. will post 3.16 earnings per share for the current year.

In related news, Director Herbert T. Buchwald sold 30,618 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $32.38, for a total transaction of $991,410.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Robert Nathaniel Martin sold 7,000 shares of the firm’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $31.79, for a total value of $222,530.00. The disclosure for this sale can be found here. Insiders have sold a total of 234,962 shares of company stock valued at $7,671,544 over the last ninety days. Insiders own 26.30% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the stock. Penserra Capital Management LLC acquired a new stake in M.D.C. during the 1st quarter valued at $56,000. Quantamental Technologies LLC grew its stake in shares of M.D.C. by 2,807.7% during the first quarter. Quantamental Technologies LLC now owns 5,641 shares of the construction company’s stock worth $164,000 after purchasing an additional 5,447 shares during the period. 6 Meridian acquired a new stake in shares of M.D.C. during the first quarter worth $207,000. CIBC Asset Management Inc acquired a new stake in shares of M.D.C. during the first quarter worth $212,000. Finally, Magnus Financial Group LLC acquired a new stake in shares of M.D.C. during the fourth quarter worth $208,000. 74.68% of the stock is owned by hedge funds and other institutional investors.

About M.D.C.

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Featured Article: Penny Stocks

Get a free copy of the Zacks research report on M.D.C. (MDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.